Blog
Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
Cloud and other IT infrastructure and services provider Kyndryl Holdings Inc. (NYSE: KD) has impressed with a return of nearly 98% in the year leading to February 14, 2025. Indeed, as of that
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
Shares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 weeks. Shares are down 34% over that period as of the Feb. 13 close. The
ATN International: A Deep Value Play With a High-Powered Dividend
ATN International Inc. (NASDAQ: ATNI) owns and operates communications infrastructure in remote and underserved regions in the western U.S., Alaska, and internationally. The firm operates
Is Coinbase Stock a Buy After Earnings?
Most investors avoid investing in stocks during – and after – their earnings results, and for good reason. Volatility is usually at its peak around those days as the market adjusts and digests
3 Stocks to Hedge Against Inflation’s Persistence
Inflation is officially back—and it’s at its fastest pace since September 2023. According to the latest Consumer Price Index data, consumer prices rose 0.5% from December, resulting in an annual
Dominion Energy: Renewable Energy Lights Up Investor Optimism
Dominion Energy (NYSE: D) is a major player in the United States energy sector. The company recently released its fourth-quarter earnings report for 2024.
The quarter's financial results
Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
Markets have hit shares of robotic warehouse systems company Symbotic (NASDAQ: SYM) hard over the past 52 weeks. Shares of the industrials stock have lost nearly 37% of their value as of the Feb
High-Yield Healthcare: 3 Stocks With Strong Dividends
When it comes to dividend performers, healthcare usually takes a backseat to options like REITs and energy stocks. However, the sector’s resilience, driven by aging populations and consistent
Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Discount retailers have become an attractive investment opportunity due to the current economic climate of persistent inflation. As consumers face rising costs for goods and services, the appeal
Roblox's Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
Roblox (NYSE: RBLX), one of the hotter stocks in the gaming industry over the past 52 weeks, just had much of its 2025 gains wiped out. Prior to the company’s latest earnings report, shares were
Is Chevron Stock Primed for Growth After Profit-Boosting News?
Chevron Corp. (NYSE: CVX) announced it was laying off approximately 20% of its global workforce by the end of 2026. The company announced the moves as an effort to cut costs, simplify its
3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
If you're seeking growth in 2025, technology stocks and the semiconductor sector remain key areas to watch. Semiconductors are the foundation of the ongoing artificial intelligence (AI)
3 Consumer Staples ETFs for Stability in a Volatile Market
As reports that inflation heated up in January 2025 emerged on February 12, the market shuddered, with the Dow dropping by more than 300 points in morning trading. The recent Consumer Price Index
MarketBeat Week in Review – 02/10 - 02/14
If you believe in the Efficient Market hypothesis, you had a good week. Despite a hotter-than-expected CPI print, a rise in credit card delinquencies, and the Trump administration’s announcement of
NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
The market’s memory is still fresh when it comes to the volatility induced by the NVIDIA Co. (NASDAQ: NVDA) flash sell-off that came from the DeepSeek debacle in China. However, the relationship
Up 50% in January, Twilio’s Pullback is the Time to Buy
Twilio’s (NYSE: TWLO) pullback is the time to buy this stock because it offers an opportune discount in a high-quality tech-growth stock with AI and automation exposure. The stock price rose by
Watch These 3 Stocks—High Short Interest and Big Upside Potential
There comes a time every once in a cycle when the market gets too invested in either a bullish or bearish view, and just like any other physical marketplace, the stock market can then trigger a
Cisco Roars Back: Is the Tech Giant Reborn?
Cisco Systems (NASDAQ: CSCO) latest earnings report exceeded analyst expectations, indicating a potential resurgence for the technology company. As a result, Cisco's stock price rose to new
Albemarle’s Earnings Are In—Is the Stock a Buy Now?
Investors are typically – and justifiably – careful about investing in any given stock around the company’s earnings season since volatility is usually elevated for the days before, during, and
Forget Tesla: 3 Stocks to Ride the Elon Musk Effect
Elections have consequences, but they also create opportunities. With the 2024 election in the rearview mirror, Elon Musk is making headlines for many reasons unrelated to his multiple businesses
David Tepper Loads Up on China—These 5 Stocks Stand Out
Billionaire investor and hedge fund manager David Tepper is betting on China despite the ongoing threat of tariffs from the Trump Administration. The president and founder of Appaloosa Management
Datadog Is in the Doghouse, But This Dip Spells Opportunity
Datadog (NASDAQ: DDOG) is in the doghouse following its FQ4 2024 earnings release, but this pullback is an opportunity to buy a great stock at a discounted price. The pullback was caused by
Vertiv Stock Under Pressure: Is Opportunity Knocking?
Vertiv Holdings (NYSE: VRT), a critical infrastructure provider, recently saw its stock price drop following its latest earnings release, causing investors to reevaluate the company's position
MicroStrategy’s 8% Preferred Stock: What Investors Should Know
MicroStrategy (NASDAQ: MSTR), now doing business as Strategy, is a leading player in crypto markets and recently announced an intriguing security issuance: preferred stock. Below, I’ll describe in
Biotechs on the Brink: 2 Stocks With Huge Potential
Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to keep their doors open during a pre-revenue period while they develop drug

